Fig. 1.
Molecular structure of the three tumor necrosis factor antagonists for ulcerative colitis treatment.7 (A) Infliximab. (B) Adalimumab. (C) Golimumab.
Fc, crystalline fragment; Fv, variable fragment; Fcγ1, human immunoglobulin G1 Fc fragment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.